"Achilles' Heel" for Lymphoid Leukemia Identified, Institut de recherches cliniques de Montreal Study

Published: Feb 12, 2013

An international research team coordinated at the IRCM in Montréal found a possible alternative treatment for lymphoid leukemia. Led by Dr. Tarik Möröy, the IRCM's President and Scientific Director, the team discovered a molecule that represents the disease's "Achilles' heel" and could be targeted to develop a new approach that would reduce the adverse effects of current treatments such as chemotherapy and radiation therapy. The study's results are being published February 11 in the scientific journal Cancer Cell.

Back to news